Literature DB >> 24322718

Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy.

Piotr Czauderna1, Dolores Lopez-Terrada, Eiso Hiyama, Beate Häberle, Marcio H Malogolowkin, Rebecka L Meyers.   

Abstract

PURPOSE OF REVIEW: As a rare pediatric tumor, hepatoblastoma presents challenges to the individual practitioner as no center will see more than a handful of cases each year. RECENT
FINDINGS: The Children's Hepatic tumor International Collaborative (CHIC) effort has fostered international cooperation in this rare children's tumor, leading to the establishment of a large international collaborative dataset, the CHIC database, which has been interrogated to refine risk stratification and inform treatment options. Apace with this effort has been the international collaboration of pediatric pathologists working together to establish a new international histopathologic consensus classification for pediatric liver tumors as a whole, with particular focus on the histological subtypes of hepatoblastoma.
SUMMARY: International collaborative efforts in hepatoblastoma have led to a new international histopathologic consensus classification, refinements in risk stratification, advances in chemotherapy, and a better understanding of surgical resection options forming the foundation for the development of an upcoming international therapeutic trial.

Entities:  

Mesh:

Year:  2014        PMID: 24322718     DOI: 10.1097/MOP.0000000000000046

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  83 in total

1.  Development of the Serum α-Fetoprotein Reference Range in Patients with Beckwith-Wiedemann Spectrum.

Authors:  Kelly A Duffy; Jennifer L Cohen; Okan U Elci; Jennifer M Kalish
Journal:  J Pediatr       Date:  2019-06-22       Impact factor: 4.406

2.  Connectivity map identifies HDAC inhibition as a treatment option of high-risk hepatoblastoma.

Authors:  Alexander Beck; Corinna Eberherr; Michaela Hagemann; Stefano Cairo; Beate Häberle; Christian Vokuhl; Dietrich von Schweinitz; Roland Kappler
Journal:  Cancer Biol Ther       Date:  2016-09-16       Impact factor: 4.742

3.  American College of Radiology LI-RADS in pediatric patients: the good, the bad, and the future.

Authors:  Gary R Schooler
Journal:  Pediatr Radiol       Date:  2019-05-08

4.  A Brief Report of Immunohistochemical Markers to Identify Aggressive Hepatoblastoma.

Authors:  Vivekanand Singh; Michelle Manalang; Meenal Singh; Udayan Apte
Journal:  Appl Immunohistochem Mol Morphol       Date:  2018-10

5.  Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee.

Authors:  Howard M Katzenstein; Wayne L Furman; Marcio H Malogolowkin; Mark D Krailo; M Beth McCarville; Alexander J Towbin; Greg M Tiao; Milton J Finegold; Sarangarajan Ranganathan; Stephen P Dunn; Max R Langham; Eugene D McGahren; Carlos Rodriguez-Galindo; Rebecka L Meyers
Journal:  Cancer       Date:  2017-02-17       Impact factor: 6.860

6.  Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.

Authors:  Rebecka L Meyers; Rudolf Maibach; Eiso Hiyama; Beate Häberle; Mark Krailo; Arun Rangaswami; Daniel C Aronson; Marcio H Malogolowkin; Giorgio Perilongo; Dietrich von Schweinitz; Marc Ansari; Dolores Lopez-Terrada; Yukichi Tanaka; Rita Alaggio; Ivo Leuschner; Tomoro Hishiki; Irene Schmid; Kenichiro Watanabe; Kenichi Yoshimura; Yurong Feng; Eugenia Rinaldi; Davide Saraceno; Marisa Derosa; Piotr Czauderna
Journal:  Lancet Oncol       Date:  2016-11-22       Impact factor: 41.316

Review 7.  [Mesenchymal abdominal tumors in children].

Authors:  G A Krombach
Journal:  Radiologe       Date:  2018-01       Impact factor: 0.635

8.  Usefulness of a recanalized umbilical vein for vascular reconstruction in pediatric hepatic surgery.

Authors:  Masato Shinkai; Kyoko Mochizuki; Norihiko Kitagawa; Hiroshi Take; Hidehito Usui; Kaori Nakamura Yamoto; Shogo Fujita; Youkatsu Ohhama
Journal:  Pediatr Surg Int       Date:  2016-04-15       Impact factor: 1.827

Review 9.  Role of interventional radiology in managing pediatric liver tumors : Part 2: percutaneous interventions.

Authors:  C Matthew Hawkins; Alexander J Towbin; Derek J Roebuck; Eric J Monroe; Anne E Gill; Avnesh S Thakor; Richard B Towbin; Anne Marie Cahill; Matthew P Lungren
Journal:  Pediatr Radiol       Date:  2018-02-02

10.  Defining an optimal time window to screen for hepatoblastoma in children with Beckwith-Wiedemann syndrome.

Authors:  Alessandro Mussa; Kelly A Duffy; Diana Carli; Giovanni Battista Ferrero; Jennifer M Kalish
Journal:  Pediatr Blood Cancer       Date:  2018-09-30       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.